These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12001455)

  • 1. [Will genes become an engine to the industry?].
    Nylund S; Sibakov M
    Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
    [No Abstract]   [Full Text] [Related]  

  • 2. The end of the beginning for genomic medicine.
    Bailey D; Zanders E; Dean P
    Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent protection for protein structure analysis.
    Shimbo I; Nakajima R; Yokoyama S; Sumikura K
    Nat Biotechnol; 2004 Jan; 22(1):109-12. PubMed ID: 14704710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecting genes, drugs and diseases.
    Weinstein JN; Pommier Y
    Nat Biotechnol; 2006 Nov; 24(11):1365-6. PubMed ID: 17093484
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech round the world: focus on Canada.
    Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 7. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 8. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

  • 9. Aurora throws light on Vertex's aspirations.
    Fletcher L
    Nat Biotechnol; 2001 Jun; 19(6):496. PubMed ID: 11385416
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech boom.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
    [No Abstract]   [Full Text] [Related]  

  • 11. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 12. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 13. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 15. Five technologies to lead the biotek.
    Lubner GC
    Boll Chim Farm; 2004 Jun; 143(5):194. PubMed ID: 15360106
    [No Abstract]   [Full Text] [Related]  

  • 16. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiating genomics companies.
    James R
    Nat Biotechnol; 2000 Feb; 18(2):153-5. PubMed ID: 10657119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics joint venture 2.
    Davies MJ
    Trends Biotechnol; 2001 May; 19(5):163. PubMed ID: 11301124
    [No Abstract]   [Full Text] [Related]  

  • 19. HGS drug flop latest genomics setback.
    Reid B
    Nat Biotechnol; 2002 Jun; 20(6):533. PubMed ID: 12042841
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of bacteriophage genomics.
    McGrath S; Fitzgerald GF; van Sinderen D
    Curr Opin Biotechnol; 2004 Apr; 15(2):94-9. PubMed ID: 15081045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.